Phase 2 Immune-related Adverse Event Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
PneumonitisImmune-related Adverse Event
AHS Cancer Control Alberta94 enrolled1 locationNCT06860542
Recruiting
Phase 2
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Immune-related Adverse EventInflammatory Arthritis
Tom Appleton30 enrolled1 locationNCT06037811
Recruiting
Phase 2
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
Advanced MelanomaDiarrheaImmune-related Adverse Event+1 more
AHS Cancer Control Alberta20 enrolled1 locationNCT05663775
Recruiting
Phase 2
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Mmr DeficiencyImmune-related Adverse EventEndometrial Cancer Stage I+1 more
Queensland Centre for Gynaecological Cancer10 enrolled3 locationsNCT06278857